126 related articles for article (PubMed ID: 37955182)
41. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
Mathew OP; Ranganna K; Yatsu FM
Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
[TBL] [Abstract][Full Text] [Related]
42. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
43. Rb and FZR1/Cdh1 determine CDK4/6-cyclin D requirement in C. elegans and human cancer cells.
The I; Ruijtenberg S; Bouchet BP; Cristobal A; Prinsen MB; van Mourik T; Koreth J; Xu H; Heck AJ; Akhmanova A; Cuppen E; Boxem M; Muñoz J; van den Heuvel S
Nat Commun; 2015 Jan; 6():5906. PubMed ID: 25562820
[TBL] [Abstract][Full Text] [Related]
44. Cyclin D-CDK4/6 functions in cancer.
Gao X; Leone GW; Wang H
Adv Cancer Res; 2020; 148():147-169. PubMed ID: 32723562
[TBL] [Abstract][Full Text] [Related]
45. Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly.
Santiago FS; Ishii H; Shafi S; Khurana R; Kanellakis P; Bhindi R; Ramirez MJ; Bobik A; Martin JF; Chesterman CN; Zachary IC; Khachigian LM
Circ Res; 2007 Jul; 101(2):146-55. PubMed ID: 17556661
[TBL] [Abstract][Full Text] [Related]
46. CDC2 Is an Important Driver of Vascular Smooth Muscle Cell Proliferation via FOXM1 and PLK1 in Pulmonary Arterial Hypertension.
Pal-Ghosh R; Xue D; Warburton R; Hill N; Polgar P; Wilson JL
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203295
[TBL] [Abstract][Full Text] [Related]
47. Insights into the aberrant CDK4/6 signaling pathway as a therapeutic target in tumorigenesis.
Rezaeian AH; Inuzuka H; Wei W
Adv Protein Chem Struct Biol; 2023; 135():179-201. PubMed ID: 37061331
[TBL] [Abstract][Full Text] [Related]
48. Differential modification of p27Kip1 controls its cyclin D-cdk4 inhibitory activity.
James MK; Ray A; Leznova D; Blain SW
Mol Cell Biol; 2008 Jan; 28(1):498-510. PubMed ID: 17908796
[TBL] [Abstract][Full Text] [Related]
49. Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways.
Morris HE; Neves KB; Nilsen M; Montezano AC; MacLean MR; Touyz RM
Hypertension; 2023 Aug; 80(8):1683-1696. PubMed ID: 37254738
[TBL] [Abstract][Full Text] [Related]
50. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
51. Arterial territory-specific phosphorylated retinoblastoma protein species and CDK2 promote differences in the vascular smooth muscle cell response to mitogens.
Lange M; Fujikawa T; Koulova A; Kang S; Griffin MJ; Lassaletta AD; Erat A; Tobiasch E; Bianchi C; Elmadhun N; Sellke FW; Usheva A
Cell Cycle; 2014; 13(2):315-23. PubMed ID: 24240190
[TBL] [Abstract][Full Text] [Related]
52. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
54. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
55. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
[TBL] [Abstract][Full Text] [Related]
56. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
Wang J; Walsh K
Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
[TBL] [Abstract][Full Text] [Related]
58. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
59. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity.
Fatrai S; Elghazi L; Balcazar N; Cras-Méneur C; Krits I; Kiyokawa H; Bernal-Mizrachi E
Diabetes; 2006 Feb; 55(2):318-25. PubMed ID: 16443763
[TBL] [Abstract][Full Text] [Related]
60. Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB.
Schade AE; Oser MG; Nicholson HE; DeCaprio JA
Oncogene; 2019 Jun; 38(25):4962-4976. PubMed ID: 30833638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
